SpectronRx makes and supplies radioactive isotopes and manufactures radioactive drugs for other companies, including the kinds used to find and treat cancer. It does not have its own medicines.
SpectronRx is a US radiopharmaceutical contract development and manufacturing organisation (CDMO/RDMO) and isotope supplier. It began as Nukemed in Fishers, Indiana, and now has its main office in Indianapolis and facilities in South Bend, with a Danbury, Connecticut site opening and a west coast expansion planned. It offers radiolabelling of antibodies, nanobodies and peptides, isotope procurement, cold-chain logistics and regulatory support up to FDA filings, and lists isotopes including Ac-225, Pb-212, Lu-177, I-123/131, Ga-68, Cu-64/67, In-111 and F-18. The company says it has three CDMO facilities and works with alpha- and beta-emitting therapeutics. Its resources page centres on cancer radioligand therapy, such as lutetium-177 PSMA and DOTA-octreotate. OrbiMed's portfolio page describes it as a diagnostic and therapeutic radiopharmaceutical developer and manufacturer specialising in CDMO, CMO and isotope production.
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Radiopharmaceutical GMP and releasing a drug that decays.
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Radiopharmaceutical GMP and releasing a drug that decays.
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Radiopharmaceutical GMP and releasing a drug that decays.
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Radiopharmaceutical GMP and releasing a drug that decays.
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Radiopharmaceutical GMP and releasing a drug that decays.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/